SAN DIEGO, Oct. 14, 2019 /PRNewswire/ -- Neurocrine
Biosciences, Inc. (NASDAQ: NBIX) announced today that it will
report third quarter financial results after the Nasdaq market
closes on Monday, November 4, 2019.
Neurocrine will then host a conference call and webcast to discuss
its financial results and provide a Company update that day at
1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
Participants can access the live conference call by dialing
800-894-5910 (US) or 785-424-1052 (International) using the
conference ID: NBIX. The webcast can also be accessed on
Neurocrine's website under Investors at www.neurocrine.com. A
replay of the webcast will be available on the website
approximately one hour after the conclusion of the event and will
be archived for approximately one month.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences (Nasdaq: NBIX) is a neuroscience-focused,
biopharmaceutical company with more than 25 years of experience
discovering and developing life-changing treatments for people with
serious, challenging and under-addressed neurological, endocrine
and psychiatric disorders. The company's diverse portfolio includes
FDA-approved treatments for tardive dyskinesia and endometriosis*
and clinical development programs in multiple therapeutic areas
including Parkinson's disease, congenital adrenal hyperplasia,
uterine fibroids* and polycystic ovary syndrome*. Headquartered in
San Diego, Neurocrine Biosciences
specializes in targeting and interrupting disease-causing
mechanisms involving the interconnected pathways of the nervous and
endocrine systems. For more information, visit neurocrine.com,
and follow the company on LinkedIn. (*in collaboration
with AbbVie)
View original content to download
multimedia:http://www.prnewswire.com/news-releases/neurocrine-biosciences-announces-conference-call-and-webcast-of-third-quarter-2019-financial-results-300938065.html
SOURCE Neurocrine Biosciences, Inc.